Affordable Access

Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis.

Authors
Journal
Journal of Neurology Neurosurgery & Psychiatry
0022-3050
Publisher
BMJ
Publication Date
Keywords
  • Research Article

Abstract

The serum concentrations of the myotrophic hormone insulin-like growth factor-I (IGF-I) in 23 patients with amyotrophic lateral sclerosis were not significantly different from those found in the sera of 13 control patients. There was no difference in binding of 125I-IGF-I by serum from patients with amyotrophic lateral sclerosis in comparison with that found in the controls. These results indicate that immunoreactive IGF-I concentrations are normal in patients with amyotrophic lateral sclerosis and that such patients do not have significant antibodies binding their endogenous IGF-I.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Serum insulin-like growth factor-I levels in amyot...

on Journal of Neurology Neurosurg... June 1987

Free insulin-like growth factor (IGF)-1 and IGF-bi...

on European journal of neurology March 2010

Increased expression of insulin-like growth factor...

on Journal of Neurology Neurosurg... August 2000
More articles like this..